42 studies found for:    ARSENIC ACID
Show Display Options
RSS Create an RSS feed from your search for:
ARSENIC ACID
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated
Has Results
Trial of Arsenic Trioxide With Ascorbic Acid in the Treatment of Adult Non-Acute Promyelocytic Leukemia (APL) Acute Myelogenous Leukemia
Condition: Acute Myelogenous Leukemia
Interventions: Drug: Arsenic Trioxide (ATO);   Drug: Ascorbic Acid
2 Recruiting Study of Oral Arsenic Trioxide With or Without Ascorbic Acid in Adults With Myelofibrosis
Condition: Primary Myelofibrosis
Intervention: Drug: Dose Escalating Arsenic Trioxide plus ascorbic Acid
3 Completed
Has Results
Arsenic Trioxide With Ascorbic Acid and Melphalan for Myeloma Patients
Conditions: Multiple Myeloma;   Stem Cell Transplantation
Interventions: Drug: Arsenic Trioxide;   Drug: Melphalan;   Drug: Ascorbic Acid
4 Completed Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Dietary Supplement: ascorbic acid;   Drug: arsenic trioxide;   Drug: bortezomib;   Drug: dexamethasone;   Drug: thalidomide;   Drug: Aspirin
5 Completed
Has Results
Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Intervention: Drug: Decitabine, Arsenic Trioxide and Ascorbic Acid
6 Terminated Arsenic Trioxide, Thalidomide, Dexamethasone, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Dietary Supplement: ascorbic acid;   Drug: arsenic trioxide;   Drug: dexamethasone;   Drug: thalidomide
7 Active, not recruiting All-trans Retinoic Acid, and Arsenic +/- Gemtuzumab
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: All-Trans Retinoic Acid (ATRA);   Drug: Arsenic Trioxide (ATO);   Drug: Idarubicin
8 Recruiting Combined Retinoic Acid,Arsenic Trioxide and Chemo for Newly-diagnosed APL
Condition: Acute Promyelocytic Leukemia
Interventions: Drug: ATRA+arsenic;   Drug: ATRA+chemo
9 Completed Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder
Conditions: Chronic Myeloproliferative Disorders;   Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Diseases
Interventions: Dietary Supplement: ascorbic acid;   Drug: arsenic trioxide;   Drug: dexamethasone;   Drug: thalidomide
10 Terminated Trisenox, Ascorbic Acid and Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma
Condition: Multiple Myeloma
Intervention: Drug: Arsenic Trioxide, Ascorbic Acid and Bortezomib
11 Withdrawn Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma
Conditions: Stage I Multiple Myeloma;   Stage II Multiple Myeloma;   Stage III Multiple Myeloma;   Refractory Plasma Cell Neoplasm
Interventions: Drug: arsenic trioxide;   Drug: ascorbic acid;   Drug: dexamethasone;   Drug: thalidomide;   Procedure: anti-cytokine therapy;   Procedure: antiangiogenesis therapy;   Procedure: biological therapy;   Procedure: chemotherapy;   Procedure: drug resistance inhibition;   Procedure: growth factor antagonist therapy;   Procedure: non-specific immune-modulator therapy
12 Withdrawn Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Stage II Multiple Myeloma;   Stage III Multiple Myeloma;   Refractory Plasma Cell Neoplasm
Interventions: Drug: arsenic trioxide;   Drug: ascorbic acid;   Drug: melphalan;   Procedure: chemosensitization/potentiation;   Procedure: chemotherapy
13 Terminated Study of Association of Arsenic Trioxide (ATO) and Ascorbic Acid in Myelodysplastic Syndromes
Condition: Myelodysplastic Syndromes
Intervention: Drug: ATO + Ascorbic acid
14 Completed
Has Results
Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients
Condition: Myeloma
Interventions: Drug: Trisenox (Arsenic Trioxide);   Drug: Velcade (Bortezomib);   Drug: Melphalan;   Drug: Vitamin C (Ascorbic Acid)
15 Active, not recruiting Phase III Trial in Acute Promyelocytic Leukemia Patients
Condition: Leukemia
Interventions: Drug: arsenic trioxide;   Drug: idarubicin;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: all-trans retinoic acid;   Drug: all-trans retinoic acid (ATRA)
16 Completed Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Dietary Supplement: ascorbic acid;   Drug: arsenic trioxide
17 Completed Folic Acid and Creatine as Therapeutic Approaches for Lowering Blood Arsenic
Condition: High Blood Arsenic Due to Chronic Arsenic Exposure
Interventions: Other: Placebo;   Dietary Supplement: folic acid;   Dietary Supplement: creatine;   Dietary Supplement: creatine + folic acid
18 Completed Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia
Condition: Myelodysplastic Syndromes and Leukemia, Myeloid, Acute
Interventions: Drug: Arsenic Trioxide;   Drug: Decitabine
19 Recruiting Acute Promyelocytic Leukemia (APL) Treated With ATRA, Arsenic Trioxide and Gemtuzumab Ozogamicin
Condition: Leukemia
Interventions: Drug: ATRA;   Drug: ATO;   Drug: GO (Gemtuzumab ozogamicin);   Drug: Methylprednisolone
20 Completed Effect of Spirulina on Zinc, Vitamin E and Linoleic Acid Levels in Palm Skin Following Chronic Exposure to Arsenic
Condition: Arsenical Keratosis
Intervention: Dietary Supplement: Spirulina

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years